RecruitingNot Applicable

The MARVIN Chatbots to Provide Information for Different Health Conditions

Canada400 participantsStarted 2024-03-01

Plain-language summary

This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.

Who can participate

Age range

14 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria for all objectives: * being 14 years or older; * being fluent in English and/or French; * being able to understand the requirements of study participation and provide informed consent during the duration of the study; * having access to a smartphone, tablet, or computer at home/at workplace; * having access to an internet connection at home or data plan on their device. Inclusion Criteria Specific to objectives 2 and 3: * accept to use a Facebook Messenger-based Chatbot; * accept to use or create a personal Facebook account; * accept Facebook's privacy and data security policies. Exclusion Criteria: * not meeting the inclusion criteria * any reason, in the opinion of the investigator, which would make the candidate inappropriate for participation in an investigative study involving a chatbot (e.g., cognitive deficit)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Usability Metric for User eXperience (UMUX-Lite)

Timeframe: Immediately, after 1-month of testing - objective 2

Acceptability E-Scale (AES)

Timeframe: Immediately after 1-month of testing - objective 2

Change in Acceptability E-Scale (AES) over 12 months

Timeframe: Once every 3 months within 12 months

Change in Intervention Appropriateness Measure (IAM) over 12 months

Timeframe: Once every 3 months within 12 months

Change in Compatibility Subscale over 12 months

Timeframe: Once every 3 months within 12 months

Trial details

NCT IDNCT05789901

SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2033-12-31

Contact for this trial

Bertrand Lebouché, MD

514-843-2090 bertrand.lebouche@mcgill.ca

View on ClinicalTrials.gov More HIV Infections trials

Plain-language summary

Who can participate

Age range

14 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Usability Metric for User eXperience (UMUX-Lite)

Timeframe: Immediately, after 1-month of testing - objective 2

Acceptability E-Scale (AES)

Timeframe: Immediately after 1-month of testing - objective 2

Change in Acceptability E-Scale (AES) over 12 months

Timeframe: Once every 3 months within 12 months

Change in Intervention Appropriateness Measure (IAM) over 12 months

Timeframe: Once every 3 months within 12 months

Change in Compatibility Subscale over 12 months

Timeframe: Once every 3 months within 12 months